See the source article by following the link below:
A new study found that patients on a new drug for multiple sclerosis , or MS, was able to reduce the rate of brain shrinkage in a Phase 2 clinical trial, which may be key to slowing the onset of symptoms
A new study found that patients on a new drug for multiple sclerosis , or MS, was able to reduce the rate of brain shrinkage in a Phase 2 clinical trial, which may be key to slowing the onset of symptoms
No comments:
Post a Comment